Welcome

We are a specialty pharmaceutical company developing a new generation of pharmaceutical and biopharmaceutical products using our proprietary drug formulation technologies.


Featured technology

Our Diffucaps® technology is a multiparticulate system that provides optimal release profiles for either single drugs or for a combination of drugs.

Read more about featured technology


Featured products

  • EUR-1008 (Zenpep™)

    EUR-1008 is a new proprietary product developed for the treatment of Exocrine Pancreatic Insufficiency, commonly associated with cystic fibrosis and chronic pancreatitis. The NDA is currently under review; approvable letter issued by the FDA June 2008.

    Read more about EUR-1008 (Zenpep™)